BSE filing, BSE: 532154. Summary written from the filing by ALFA Finder's alert engine.
Johnson Pharmacare Ltd: key numbers
- Share price
- ₹0.40
- Market cap
- ₹22.00 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-55.73 Cr
- P/E (TTM)
- -0.4×Sector 43.1×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Johnson Pharmacare Ltd
All →Johnson Pharmacare Other Announcement
Johnson Pharmacare Limited has approved the shifting of its registered office within the local limits of Ahmedabad. This administrative change was approved at their board meeting.
Johnson Pharmacare Board Meeting Date
Johnson Pharmacare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the standalone unaudited financial results for the quarter ending June 30, 2026.
Johnson Pharmacare Other Announcement
Johnson Pharmacare Ltd has submitted its quarterly shareholding pattern filing for the period ending June 30, 2026, as required by regulatory norms.
Johnson Pharmacare Management Change
Company Secretary Neha Srivastava resigned from the board effective June 11, 2026. The board acknowledges the change with no other material impact.
Johnson Pharmacare Other Announcement
Johnson Pharmacare filed its Annual Secretarial Compliance Report for FY2026. The report notes non-compliances regarding SDD maintenance and the appointment of internal auditors and a CFO.
Johnson Pharmacare Financial Results
Johnson Pharmacare reported audited financial results for the year ended March 31, 2026. The company faces a ₹21.40 Crore debt burden and auditor qualifications regarding internal controls.
- Value
- ₹21.40 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.